Staff20142015201620172018
Personnel at the end of the year133,413122,966122,985126,457125,161
Staff turnover in EUR356,485364,791357,933352,346376,226
Turnover LabelEUREUREUREUREUR
The share: stated in EUR20142015201620172018
Shares outstanding (in mn.)1,001.00991.00972.002,311.17944.00
Dividend per share2.452.62.72.752.8
Basic earnings per share4.217.402.823.285.44
P/L in EUR million under IAS/IFRS20142015201620172018
Turnover52,419.049,440.048,518.049,109.051,900.0
Operating income (EBIT)11,134.47,380.07,092.48,164.812,552.5
Earnings before taxes12,272.08,134.07,817.08,999.013,835.0
Annual net profit/ loss10,210.017,783.06,712.07,703.012,614.0
Balance sheet in EUR million under IAS/IFRS20142015201620172018
Assets
Total current assets37,561.022,845.024,931.028,208.034,756.0
Total fixed assets87,826.0108,711.0105,193.0104,871.0110,000.0
Total assets125,387.0131,556.0130,124.0133,079.0145,563.0
Liabilities
Total short-term liabilities26,973.023,708.022,209.023,403.029,607.0
Total long-term liabilities27,570.030,726.033,024.035,449.037,264.0
Total provisions0.00.00.00.00.0
Equity capital70,766.077,046.074,832.074,168.078,614.0
Total liabilities125,387.0131,556.0130,124.0133,079.0145,563.0
Management:
Vasant Narasimhan
Steven Baert
Steffen Lang
Shannon Thyme Klinger
Robert Weltevreden
Richard Saynor
Marie-France Tschudin
Klaus Moosmayer
John Tsai
Harry Kirsch
Bertrand Bodson
Susanne Schaffert
James E. Bradner
Board:
William T. Winters
Ton Buechner
Patrice Bula
Frans van Houten
Elizabeth Doherty
Charles L. Sawyers
Ann Fudge
Srikant Datar
Nancy C. Andrews
Enrico Vanni
Charlotte Pamer-Wieser
Andreas von Planta
Joerg Reinhardt
Shareholding in %:
Emasan AG 3.5
Novartis Foundation for Employee Participation 2.3
UBS Fund Management 2.2
free float 92
Address: Lichtstrasse, CH-4002 Basel
T: +41-61-324-1111
F: +41-61-324-8001
I: http://www.novartis.com
E: investor.relations@novartis.com